Does Dr. ZAID ABU RAJAB ALTAMIMI have financial conflicts of interest?

Dr. ZAID ABU RAJAB ALTAMIMI (MBBS) has received a total of $1,451 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,451 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ZAID ABU RAJAB ALTAMIMI?

According to CMS Open Payments data, Dr. ZAID ABU RAJAB ALTAMIMI received funding from ACCLARENT ($1,112), SMITH+NEPHEW ($273), and STRYKER CORPORATION ($38).

Does Dr. ZAID ABU RAJAB ALTAMIMI receive research grants or speaking fees?

Dr. ZAID ABU RAJAB ALTAMIMI has received $1,451 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ZAID ABU RAJAB ALTAMIMI

MBBSReal-Time Hydrated

Specialty: Otolaryngology, Pediatric Otolaryngology

Practice Location: HOUSTON, TX 77030

NPI Number: 1285215152

LIFETIME INDUSTRY VALUE

$1,451

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABU RAJAB ALTAMIMI is a verified Otolaryngology, Pediatric Otolaryngology practitioner based in HOUSTON, TX.

Between 2021 and 2024, Dr. ABU RAJAB ALTAMIMI had an overall industry promotional and research financial footprint of $1,451 as recorded in the federal CMS Open Payments database.

$1,451 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU RAJAB ALTAMIMI's primary funding source is ACCLARENT, which accounts for $1,112 (representing 76.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ACCLARENT

Rank 1

$1,112

76.6%

SMITH+NEPHEW

Rank 2

$273

18.8%

STRYKER CORPORATION

Rank 3

$38

2.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.